44 -1 (87) 2026 - Khamdamov B.Z., Abdurakhmanov S.M. - IMPROVEMENT OF METHODS FOR PREVENTING RESTENOSIS AFTER CORONARY ARTERY STENTING

IMPROVEMENT OF METHODS FOR PREVENTING RESTENOSIS AFTER CORONARY ARTERY STENTING

Khamdamov B.Z. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Abdurakhmanov S.M. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Measures aimed at predicting and preventing restenosis after coronary artery stenting have significantly reduced not only its incidence, but also its severity, the urgency of its manifestation, and the burden on the healthcare system.

Keywords: Coronary heart disease, coronary arteries, stenting, restenosis

First page

252

Last page

255

For citation:Khamdamov B.Z., Abdurakhmanov S.M. - IMPROVEMENT OF METHODS FOR PREVENTING RESTENOSIS AFTER CORONARY ARTERY STENTING//New Day in Medicine 1(87)2026 252-255 https://newdayworldmedicine.com/en/new_day_medicine/1-87-2026

List of References

1. Bazarov AV, Savenkov Yu.V., Shmatkov AA, et al. Modern aspects of prevention and treatment of restenosis after PCI // Russian Journal of Cardiology. 2020;5:20-26
2. Tarnovskaya NL, Solovieva OA, Rak AV, et al. Systemic inflammatory indices as new markers of unfavorable prognosis in cardiovascular diseases // Cardiovascular Therapy and Prevention. 2023;22(2):50-56.
3. Alexandrescu D.-M., Mitu O., Costache I.I., et al. Risk factors associated with intra-stent restenosis after percutaneous coronary intervention // Exp. Ther. Med. 2021;22:11-41.
4. Alexandrescu D., Crisan A., Mitu O., et al. Antiplatelet Therapy and Inflammatory Status Associated with Intra Stent Restenosis after Percutaneous Coronary Intervention // Med.-Surg. J. 2021;125:335-342.
5. Alfonso F., Byrne R.A., Rivero F., et al. Current treatment of in-stent restenosis // Journal of the American College of Cardiology. 2024;63(24):2659-2673.
6. Chen M., Lin Y., Guo W., et al. BMSC-derived exosomes carrying miR-26a-5p ameliorate spinal cord injury via negatively regulating EZH2 and activating the BDNF-TrkB-CREB signaling // Mol. Neurobiol. 2024;61:8156-8174
7. Cimmino G., Di Serafino L., Cirillo P. Pathophysiology and mechanisms of Acute Coronary Syndromes: atherothrombosis, immune-inflammation, and beyond // Expert Rev Cardiovasc Ther. 2022;20(5):351-362.
8. Dinc R., Yerebakan H. Atlas drug-eluting coronary stents inhibits neointimal hyperplasia in sheep modeling // bioRxiv. 2023. – Preprint.
9. Duan R., Du W., Guo W. Ezh2: A novel target for cancer treatment // J. Hematol. Oncol. 2020;13:104.
10. Elbadawi A., Dang A.T., Mahana I., et al. Outcomes of Percutaneous Coronary Intervention for In-Stent Restenosis Versus De Novo Lesions: A Meta-Analysis // J. Am. Heart Assoc. 2023;12:29300.

    file

    download